Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
Cover of the book

2019 | OriginalPaper | Chapter

1. Nanomaterials for Its Use in Biomedicine: An Overview

Authors : Caitlin Lazurko, Erik Jacques, Manuel Ahumada, Emilio I. Alarcon

Published in: Nanoengineering Materials for Biomedical Uses

Publisher: Springer International Publishing

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

The rapid incorporation of nanostructures in regenerative medicine can be considered one of the biggest leaps in the production of novel materials for repair and regeneration of damaged tissues. However, despite a large number of articles published, clinical use of these materials is still in its infancy. The complexity and interdisciplinary nature of research aimed to repair damaged tissue and failing organs are the main limiting factors that have halted the progression for developing novel structures for tissue repair. In the present chapter, we revise fundamental concepts to be considered when designing technologies that will have to undergo scrutiny by regulatory agencies prior to being used in humans.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now
next chapter Synthesis and Characterization of Nanomaterials for Biomedical Applications
Literature
1.
Nanoscience and nanotechnologies: opportunities and uncertainties. London, UK: The Royal Society and The Royal Academy of Engineering; 2004.
2.
Taniguchi N. On the basic concept of nanotechnology. In: Proceedings of the international conference on production engineering. Tokyo, Japan: Japan Society of Precision Engineering; 1974.
3.
Goesmann H, Feldmann C. Nanoparticulate functional materials. Angew Chem. 2010;49(8):1362–95.CrossRef
4.
Krukemeyer MGKV, Huebner F, Wagner W, Resch R. History and possible uses of nanomedicine based on nanoparticles and nanotechnological progress. J Nanomed Nanotechnol. 2015;6(6):336.
5.
Stamplecoskie K. Silver nanoparticles: from bulk material to colloidal nanoparticles. In: Alarcon EI, Griffith M, Udekwu KI, editors. Silver nanoparticle applications: in the fabrication and design of medical and biosensing devices. Cham: Springer International Publishing; 2015. p. 1–12.
6.
Ventola CL. The nanomedicine revolution: part 1: emerging concepts. P T. 2012;37(9):512–25.
7.
Lehner R, Wang X, Marsch S, Hunziker P. Intelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical application. Nanomed Nanotechnol Biol Med. 2013;9(6):742–57.CrossRef
8.
Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13(1):238-IN27.CrossRef
9.
Wagner V, Dullaart A, Bock A-K, Zweck A. The emerging nanomedicine landscape. Nat Biotechnol. 2006;24:1211.CrossRef
10.
Sampogna G, Guraya SY, Forgione A. Regenerative medicine: historical roots and potential strategies in modern medicine. J Microsc Ultrastruct. 2015;3(3):101–7.CrossRef
11.
Slingerland AS, Smits AIPM, Bouten CVC. Then and now: hypes and hopes of regenerative medicine. Trends Biotechnol. 2013;31(3):121–3.CrossRef
12.
Kaul H, Ventikos Y. On the genealogy of tissue engineering and regenerative medicine. Tissue Eng Part B. 2015;21(2):203–17.CrossRef
13.
Berthiaume F, Maguire TJ, Yarmush ML. Tissue engineering and regenerative medicine: history, progress, and challenges. Annu Rev Chem Biomol Eng. 2011;2(1):403–30.CrossRef
14.
Kemp P. History of regenerative medicine: looking backwards to move forwards. Regen Med. 2006;1(5):653–69.CrossRef
15.
Lysaght MJ, Hazlehurst AL. Tissue engineering: the end of the beginning. Tissue Eng. 2014;383(9913):193–5.
16.
Lysaght MJ, Jaklenec A, Deweerd E. Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Eng Part A. 2008;14(2):305–15.CrossRef
17.
Mason C, Dunnill P. A brief definition of regenerative medicine. Regen Med. 2008;3(1):1–5.CrossRef
18.
Chen C, Dubin R, Kim MC. Emerging trends and new developments in regenerative medicine: a scientometric update (2000–2014). Expert Opin Biol Ther. 2014;14(9):1295–317.CrossRef
19.
Bhat S, Kumar A. Biomaterials and bioengineering tomorrow’s healthcare. Biomatter. 2013;3(3):e24717.CrossRef
20.
De Jong WH, Borm PJA. Drug delivery and nanoparticles:applications and hazards. Int J Nanomed. 2008;3(2):133–49.CrossRef
21.
Yao J, Yang M, Duan Y. Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnostics, and therapy. Chem Rev. 2014;114(12):6130–78.CrossRef
22.
Bhushan B. Introduction to nanotechnology. In: Bhushan B, editor. Springer handbook of nanotechnology. Berlin, Heidelberg: Springer Berlin Heidelberg; 2017. p 1–19.CrossRef
23.
Dreher KL. Health and environmental impact of nanotechnology: toxicological assessment of manufactured nanoparticles. Toxicol Sci. 2004;77(1):3–5.CrossRef
24.
McLaughlin S, Ahumada M, Franco W, Mah TF, Seymour R, Suuronen EJ, Alarcon EI. Sprayable peptide-modified silver nanoparticles as a barrier against bacterial colonization. Nanoscale. 2016;8(46):19200–3.CrossRef
25.
Lam C-W, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci. 2004;77(1):126–34.CrossRef
26.
Ahumada M, Suuronen EJ, Alarcon EI. Biomolecule silver nanoparticle-based materials for biomedical applications. In: Martínez LMT, Kharissova OV, Kharisov BI, editors. Handbook of ecomaterials. Cham: Springer International Publishing; 2017. p. 1–17.
27.
Burdusel AC, Gherasim O, Grumezescu AM, Mogoanta L, Ficai A, Andronescu E. Biomedical applications of silver nanoparticles: an up-to-date overview. Nanomaterials (Basel). 2018;8(9).CrossRef
28.
Fei Yin Z, Wu L, Gui Yang H, Hua Su Y. Recent progress in biomedical applications of titanium dioxide. Phys Chem Chem Phys. 2013;15(14):4844–58.CrossRef
29.
Goel S, Chen F, Cai W. Synthesis and biomedical applications of copper sulfide nanoparticles: from sensors to theranostics. Small. 2014;10(4):631–45.CrossRef
30.
Elahi N, Kamali M, Baghersad MH. Recent biomedical applications of gold nanoparticles: a review. Talanta. 2018;184:537–56.CrossRef
31.
Maitz MF. Applications of synthetic polymers in clinical medicine. Biosurf Biotribol. 2015;1(3):161–76.CrossRef
32.
Andonova V. Synthetic polymer-based nanoparticles: intellogent drug delivery systems. In: Reddy B, editor. Acrylic polymers in healthcare. London, UK: IntechOpen; 2017. p. 27.
33.
Olatunji O. Biomedical application of natural polymers. In: Olatunji O, editor. Natural polymers: industry techniques and applications. Cham: Springer International Publishing; 2016. p. 93–114.CrossRef
34.
Aravamudhan A, Ramos DM, Nada AA, Kumbar SG. Chapter 4—Natural polymers: polysaccharides and their derivatives for biomedical applications. In: Kumbar SG, Laurencin CT, Deng M, editors. Natural and synthetic biomedical polymers. Oxford: Elsevier; 2014. p. 67–89.CrossRef
35.
Jain A, Singh SK, Arya SK, Kundu SC, Kapoor S. Protein nanoparticles: promising platforms for drug delivery applications. ACS Biomater Sci Eng. 2018;4(12):3939–61.CrossRef
36.
Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release. 2008;132(3):171–83.CrossRef
37.
Ahumada M, Lissi E, Montagut AM, Valenzuela-Henriquez F, Pacioni NL, Alarcon EI. Association models for binding of molecules to nanostructures. Analyst. 2017;142(12):2067–89.CrossRef
38.
Wei G, Ma PX. Nanostructured biomaterials for regeneration. Adv Funct Mater. 2008;18(22):3566–82.CrossRef
39.
Terzic A, Pfenning MA, Gores GJ, Harper CM Jr. Regenerative medicine build-out. Stem Cells Transl Med. 2015;4(12):1373–9.CrossRef
40.
Allickson JG. Emerging translation of regenerative therapies. Clin Pharmacol Ther. 2017;101(1):28–30.CrossRef
41.
Broughton KM, Sussman MA. Enhancement strategies for cardiac regenerative cell therapy. Circ Res. 2018;123(2):177–87.CrossRef
42.
Greenwood HL, Thorsteinsdottir H, Perry G, Renihan J, Singer P, Daar A. Regenerative medicine: new opportunities for developing countries. Int J Biotechnol. 2006;8(1–2):60–77.CrossRef
43.
Caplan AI, West MD. Progressive approval: a proposal for a new regulatory pathway for regenerative medicine. Stem Cells Transl Med. 2014;3(5):560–3.CrossRef
44.
Hunsberger J, Harrysson O, Shirwaiker R, Starly B, Wysk R, Cohen P, Allickson J, Yoo J, Atala A. Manufacturing road map for tissue engineering and regenerative medicine technologies. Stem Cells Transl Med. 2015;4(2):130–5.CrossRef
45.
Li MD, Atkins H, Bubela T. The global landscape of stem cell clinical trials. Regen Med. 2014;9(1):27–39.CrossRef
46.
Mount NM, Ward SJ, Kefalas P, Hyllner J. Cell-based therapy technology classifications and translational challenges. Philos Trans R Soc Lond B Biol Sci. 2015;370(1680).CrossRef
47.
Heathman TR, Nienow AW, McCall MJ, Coopman K, Kara B, Hewitt CJ. The translation of cell-based therapies: clinical landscape and manufacturing challenges. Regen Med. 2015;10(1):49–64.CrossRef
48.
Marincola FM. The trouble with translational medicine. J Intern Med. 2011;270(2):123–7.CrossRef
49.
Mason C, McCall MJ, Culme-Seymour EJ, Suthasan S, Edwards-Parton S, Bonfiglio GA, Reeve BC. The global cell therapy industry continues to rise during the second and third quarters of 2012. Cell Stem Cell. 2012;11(6):735–9.CrossRef
50.
Faulkner A. Law’s performativities: shaping the emergence of regenerative medicine through European Union legislation. Soc Stud Sci. 2018;42(5):753–74.CrossRef
51.
Tobita M, Konomi K, Torashima Y, Kimura K, Taoka M, Kaminota M. Japan’s challenges of translational regenerative medicine: act on the safety of regenerative medicine. Regen Med. 2016;4:78–81.
52.
Singh M, Singh S, Prasad S, Gambhir IS. Nanotechnology in medicine and antibacterial effect of silver nanopartices. Digest J Nanomater Biostruct. 2008;3(3):115–22.
Metadata
Title
Nanomaterials for Its Use in Biomedicine: An Overview
Authors
Caitlin Lazurko
Erik Jacques
Manuel Ahumada
Emilio I. Alarcon
Copyright Year
2019
Book
Nanoengineering Materials for Biomedical Uses

Print ISBN: 978-3-030-31260-2

Electronic ISBN: 978-3-030-31261-9

Copyright Year: 2019

DOI
https://doi.org/10.1007/978-3-030-31261-9_1

Premium Partners

    Image Credits